Medical device manufacturer
Appears in 1 story
Competitor with FDA-approved pacing lead for left bundle branch area
For decades, implantable defibrillators have saved lives by shocking dangerously fast heart rhythms back to normal — but the leads that deliver those shocks also pace the heart in an unnatural pattern that can itself cause damage over time. Medtronic's OmniaSecure lead, now cleared by the Food and Drug Administration (FDA) for placement in the left bundle branch area, is the first defibrillation lead that can also pace through the heart's own electrical wiring, closely mimicking natural heartbeats.
Updated 3 hours ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
